Skip to main content
Log in

Binding of thioridazine and thioridazine metabolites to serum proteins

An in vitro study

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The binding constants of the binding between thioridazine and its metabolites, side-chain sulfoxide, sidechain sulfone and ring sulfoxide, on the one hand, and the plasma proteins, α1-acid glycoprotein, albumin and total serum proteins, on the other, were determined. The binding constants between the drug substances and α1-acid glycoprotein were found to be about a thousand times higher than the binding constants between the drug substances and albumin. The binding constants of whole serum were close to those of α1-acid glycoprotein. Analysis of the binding data indicated competition between thioridazine and its metabolites.

A number of drug substances were screened for possible binding interaction with thioridazine and its metabolites. Tricyclic antidepressants and propranolol significantly increased the free concentration of thioridazine. Also salicyclic acid and the plasticizing agent, TBEP, had this effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Axelsson R, Mårtensson E, Alling C (1982) Serum concentrations and protein binding of thioridazine and its metabolites in patients with chronic alcoholism. Eur J Clin Pharmacol (in press)

  • Basett RC, Wright AA, Gross EM, Hine CM (1978) Human tissue distribution of thioridazine during therapy and after poisoning. J Anal Toxicol 2:41–43

    Google Scholar 

  • Nyberg G, Axelsson R, Mårtensson E (1978) Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients. Eur J Clin Pharmacol 14:341–350

    Google Scholar 

  • Nyberg G, Axelsson R, Mårtensson E (1981) Cerebrospinal fluid concentrations of thioridazine and its main metabolites in psychiatric patients. Eur J Clin Pharmacol 19:139–148

    Google Scholar 

  • Piafsky K, Borgå O (1977a) Plasma protein binding of basic drugs (I): Selective displacement from α1-acid glycoprotein by tris-(butoxyethyl)phosphate. Clin Pharmacol Ther 22:539–544

    Google Scholar 

  • Piafsky K, Borgå O (1977b) Plasma protein binding of basic drugs (II): Importance of α1-acid glycoprotein for interindividual variation. Clin Pharmacol Ther 22:545–549

    Google Scholar 

  • Scatchard G (1949) The attraction of proteins for small molecules and ions. Ann NY Sci 51:660–672

    Google Scholar 

  • Vallner J (1977) Binding of drugs by albumin and plasma protein (review). J Pharmacol Sci 66:447–465

    Google Scholar 

  • Veronese FM, Bevilacqua R, Chaiken IM (1978) Drug-protein interactions: evaluation of the binding of antipsychotic drugs to glutamate-dehydrogenase by quantitative affinity chromatography. Mol Pharmacol 15:313–321

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nyberg, G., Mårtensson, E. Binding of thioridazine and thioridazine metabolites to serum proteins. Naunyn-Schmiedeberg's Arch. Pharmacol. 319, 189–196 (1982). https://doi.org/10.1007/BF00495864

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00495864

Key words

Navigation